SIMILAR PATTERNS OF AMINO ACIDS FOR 2XYT_G_TC9G1206

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h2w HOMOSERINE
O-SUCCINYLTRANSFERAS
E

(Thermotoga
maritima) 		PF04204
(HTS) 		4 TYR A 262
CYH A 142
GLU A 236
TYR A 237
 None
 1.41A 2xytG-2h2wA:
undetectable		 2xytG-2h2wA:
21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2m9a E3 UBIQUITIN-PROTEIN
LIGASE ZFP91

(Homo sapiens) 		PF00096
(zf-C2H2) 		4 TYR A  18
CYH A  19
CYH A  16
GLU A  17
 None
ZN  A 101 (-2.3A)
ZN  A 101 (-2.3A)
None
 1.25A 2xytG-2m9aA:
undetectable		 2xytG-2m9aA:
17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vdj HOMOSERINE
O-SUCCINYLTRANSFERAS
E

(Bacillus cereus) 		PF04204
(HTS) 		4 TYR A 263
CYH A 142
GLU A 237
TYR A 238
 None
HSE  A1298 (-3.3A)
None
None
 1.42A 2xytG-2vdjA:
0.0		 2xytG-2vdjA:
22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bwk CYSTEINE PROTEASE
FALCIPAIN-3

(Plasmodium
falciparum) 		PF00112
(Peptidase_C1) 		4 TRP A 215
TYR A 173
GLU A 221
TYR A 168
 C1P  A 300 (-4.0A)
None
None
None
 1.46A 2xytG-3bwkA:
0.0		 2xytG-3bwkA:
18.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g4f (+)-DELTA-CADINENE
SYNTHASE ISOZYME XC1

(Gossypium
arboreum) 		PF01397
(Terpene_synth)
PF03936
(Terpene_synth_C) 		4 TYR A 472
CYH A 471
GLU A 475
TYR A 476
 None
 1.30A 2xytG-3g4fA:
undetectable		 2xytG-3g4fA:
19.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ju1 ENOYL-COA
HYDRATASE/ISOMERASE
FAMILY PROTEIN

(Shewanella
oneidensis) 		PF16113
(ECH_2) 		4 TYR A 163
TRP A 321
TYR A 110
GLU A 107
 None
 1.40A 2xytG-3ju1A:
0.0		 2xytG-3ju1A:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pz9 MANNAN
ENDO-1,4-BETA-MANNOS
IDASE. GLYCOSYL
HYDROLASE FAMILY 5

(Thermotoga
petrophila) 		PF00150
(Cellulase) 		4 TYR A 318
TRP A 335
GLU A 388
TYR A 389
 None
 1.44A 2xytG-3pz9A:
0.0		 2xytG-3pz9A:
18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tat TYROSINE
AMINOTRANSFERASE

(Escherichia
coli) 		PF00155
(Aminotran_1_2) 		4 TYR A 263
TYR A 225
CYH A 191
CYH A 192
 None
 1.40A 2xytG-3tatA:
0.0		 2xytG-3tatA:
20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tsw TIGHT JUNCTION
PROTEIN ZO-1

(Homo sapiens) 		PF00595
(PDZ)
PF00625
(Guanylate_kin)
PF07653
(SH3_2) 		4 TYR A 633
TRP A 557
GLU A 530
TYR A 527
 None
 1.28A 2xytG-3tswA:
undetectable		 2xytG-3tswA:
20.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bom ENVELOPE
GLYCOPROTEIN B

(Human
alphaherpesvirus
1) 		PF00606
(Glycoprotein_B)
PF17416
(Glycoprot_B_PH1)
PF17417
(Glycoprot_B_PH2) 		4 TYR A 114
CYH A 573
CYH A 116
GLU A 622
 None
 1.34A 2xytG-4bomA:
0.0		 2xytG-4bomA:
15.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hqp ALPHA7 NICOTINIC
RECEPTOR CHIMERA

(Homo sapiens;
Lymnaea
stagnalis) 		PF02931
(Neur_chan_LBD) 		4 TYR A  91
TRP A 145
TYR A 184
TYR A 191
 None
 0.57A 2xytG-4hqpA:
26.0		 2xytG-4hqpA:
36.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ip4 MANDELATE
RACEMASE/MUCONATE
LACTONIZING
ENZYME-LIKE PROTEIN

(Ruegeria sp.
TM1040) 		PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C) 		4 TRP A 131
TYR A 367
CYH A 371
TYR A 183
 None
 1.47A 2xytG-4ip4A:
undetectable		 2xytG-4ip4A:
18.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4jhz BETA-GLUCURONIDASE

(Escherichia
coli) 		PF00703
(Glyco_hydro_2)
PF02836
(Glyco_hydro_2_C)
PF02837
(Glyco_hydro_2_N) 		4 TYR A 468
TYR A 533
GLU A 546
TYR A 505
 1KV  A 701 ( 4.5A)
None
None
None
 1.41A 2xytG-4jhzA:
undetectable		 2xytG-4jhzA:
16.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4l37 ARYLPHORIN

(Bombyx mori) 		PF00372
(Hemocyanin_M)
PF03722
(Hemocyanin_N)
PF03723
(Hemocyanin_C) 		4 TYR B 374
TRP B 277
GLU B 424
TYR B 421
 None
 1.48A 2xytG-4l37B:
undetectable		 2xytG-4l37B:
14.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4noh LIPOPROTEIN,
PUTATIVE

(Bacillus
anthracis) 		PF17294
(Lipoprotein_22) 		4 TYR A 146
TYR A  36
GLU A 188
TYR A 142
 None
 1.38A 2xytG-4nohA:
undetectable		 2xytG-4nohA:
21.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rkc AROMATIC AMINO ACID
AMINOTRANSFERASE

(Psychrobacter
sp. B6) 		PF00155
(Aminotran_1_2) 		4 TYR A 251
TYR A 214
CYH A 180
CYH A 181
 None
PMP  A 409 ( 4.5A)
None
None
 1.26A 2xytG-4rkcA:
undetectable		 2xytG-4rkcA:
20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wd2 AROMATIC-AMINO-ACID
TRANSAMINASE TYRB

(Burkholderia
cenocepacia) 		PF00155
(Aminotran_1_2) 		4 TYR A 251
TYR A 214
CYH A 180
CYH A 181
 LLP  A 246 ( 4.6A)
LLP  A 246 ( 4.0A)
None
None
 1.31A 2xytG-4wd2A:
undetectable		 2xytG-4wd2A:
20.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zjs ACETYLCHOLINE
RECEPTOR SUBUNIT
ALPHA,SOLUBLE
ACETYLCHOLINE
RECEPTOR,ACETYLCHOLI
NE RECEPTOR SUBUNIT
ALPHA,SOLUBLE
ACETYLCHOLINE
RECEPTOR

(Aplysia
californica;
Homo sapiens) 		PF02931
(Neur_chan_LBD) 		5 TYR A  93
TRP A 147
TYR A 188
GLU A 193
TYR A 195
 None
 0.83A 2xytG-4zjsA:
29.4		 2xytG-4zjsA:
78.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5msy GLYCOSIDE HYDROLASE

(Bacteroides
thetaiotaomicron) 		PF12904
(Collagen_bind_2)
PF13204
(DUF4038) 		4 TYR A  77
TRP A 347
TYR A 356
GLU A 288
 None
 1.07A 2xytG-5msyA:
undetectable		 2xytG-5msyA:
17.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5xgl SOLUBLE
ACETYLCHOLINE
RECEPTOR

(Aplysia
californica) 		no annotation 4 TYR A  91
TRP A 145
GLU A 191
TYR A 193
 None
 0.40A 2xytG-5xglA:
31.4		 2xytG-5xglA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cc0 LUXR FAMILY
TRANSCRIPTIONAL
REGULATOR

(Pseudomonas
aeruginosa) 		no annotation 4 TRP A 102
TYR A  66
GLU A  69
TYR A  71
 EWM  A 301 (-4.9A)
EWM  A 301 (-4.4A)
None
None
 1.38A 2xytG-6cc0A:
undetectable		 2xytG-6cc0A:
17.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1b3q PROTEIN (CHEMOTAXIS
PROTEIN CHEA)

(Thermotoga
maritima) 		PF01584
(CheW)
PF02518
(HATPase_c)
PF02895
(H-kinase_dim) 		4 THR A 531
MET A 521
ILE A 523
ASP A 449
 None
 1.05A 2xytH-1b3qA:
0.0		 2xytH-1b3qA:
20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dqu ISOCITRATE LYASE

(Aspergillus
nidulans) 		PF00463
(ICL) 		4 THR A 244
ILE A 392
ASP A 198
SER A 246
 None
 1.00A 2xytH-1dquA:
0.0		 2xytH-1dquA:
17.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e1c METHYLMALONYL-COA
MUTASE ALPHA CHAIN

(Propionibacterium
freudenreichii) 		PF01642
(MM_CoA_mutase)
PF02310
(B12-binding) 		4 THR A 121
ILE A 174
ASP A 118
SER A 127
 None
 1.05A 2xytH-1e1cA:
0.0		 2xytH-1e1cA:
15.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ex9 LACTONIZING LIPASE

(Pseudomonas
aeruginosa) 		PF00561
(Abhydrolase_1) 		4 THR A 103
TYR A 196
ILE A 243
SER A 101
 None
 1.01A 2xytH-1ex9A:
undetectable		 2xytH-1ex9A:
20.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ezv UBIQUINOL-CYTOCHROME
C REDUCTASE COMPLEX
14 KD PROTEIN
UBIQUINOL-CYTOCHROME
C REDUCTASE COMPLEX
CORE PROTEIN I
UBIQUINOL-CYTOCHROME
C REDUCTASE COMPLEX
UBIQUINONE-BINDING
PROTEIN QP-C

(Saccharomyces
cerevisiae) 		PF00675
(Peptidase_M16)
PF02271
(UCR_14kD)
PF02939
(UcrQ)
PF05193
(Peptidase_M16_C) 		4 TYR F  73
GLN G  21
ARG A 251
ILE G  24
 None
 1.00A 2xytH-1ezvF:
undetectable		 2xytH-1ezvF:
19.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fsk ANTIBODY HEAVY CHAIN
FAB

(Mus musculus) 		PF07654
(C1-set)
PF07686
(V-set) 		4 THR C  71
TYR C  80
GLN C  82
ILE C  19
 None
 0.81A 2xytH-1fskC:
0.0		 2xytH-1fskC:
24.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1lt8 BETAINE-HOMOCYSTEINE
METHYLTRANSFERASE

(Homo sapiens) 		PF02574
(S-methyl_trans) 		4 TYR A 284
ILE A 281
ASP A 220
SER A 224
 None
None
CIT  A 701 (-2.8A)
None
 1.10A 2xytH-1lt8A:
undetectable		 2xytH-1lt8A:
19.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1n7r HYALURONIDASE

(Streptococcus
pneumoniae) 		PF02278
(Lyase_8)
PF02884
(Lyase_8_C)
PF08124
(Lyase_8_N) 		4 THR A 519
GLN A 418
ARG A 355
ILE A 184
 BDP  A1005 (-3.5A)
BDP  A1005 (-3.6A)
NAG  A1004 ( 3.7A)
None
 1.14A 2xytH-1n7rA:
0.0		 2xytH-1n7rA:
15.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1n7r HYALURONIDASE

(Streptococcus
pneumoniae) 		PF02278
(Lyase_8)
PF02884
(Lyase_8_C)
PF08124
(Lyase_8_N) 		4 TYR A 520
GLN A 527
ILE A 523
ASP A 192
 None
 1.11A 2xytH-1n7rA:
0.0		 2xytH-1n7rA:
15.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pp2 CALCIUM-FREE
PHOSPHOLIPASE A2

(Crotalus atrox) 		no annotation 4 THR R  41
TYR R 113
ARG R 107
ILE R 110
 None
 1.13A 2xytH-1pp2R:
undetectable		 2xytH-1pp2R:
18.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q9h CELLOBIOHYDROLASE I
CATALYTIC DOMAIN

(Rasamsonia
emersonii) 		PF00840
(Glyco_hydro_7) 		4 THR A 113
GLN A 115
ILE A 116
ASP A 110
 None
 1.06A 2xytH-1q9hA:
0.0		 2xytH-1q9hA:
18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qge PROTEIN
(TRIACYLGLYCEROL
HYDROLASE)

(Burkholderia
glumae) 		PF00561
(Abhydrolase_1)
no annotation 		4 THR D 108
TYR D 207
ILE E 277
SER D 106
 None
 1.10A 2xytH-1qgeD:
undetectable		 2xytH-1qgeD:
22.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sl5 MDC-SIGN1B TYPE I
ISOFORM

(Homo sapiens) 		PF00059
(Lectin_C) 		4 THR A 261
TYR A 268
ARG A 312
ILE A 376
 None
 0.92A 2xytH-1sl5A:
undetectable		 2xytH-1sl5A:
20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sl6 C-TYPE LECTIN
DC-SIGNR

(Homo sapiens) 		PF00059
(Lectin_C) 		4 THR A 273
TYR A 280
ARG A 324
ILE A 388
 None
 0.94A 2xytH-1sl6A:
undetectable		 2xytH-1sl6A:
19.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tah LIPASE

(Burkholderia
glumae) 		no annotation 4 THR B 108
TYR B 207
ILE B 277
SER B 106
 None
 1.11A 2xytH-1tahB:
undetectable		 2xytH-1tahB:
20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1um1 KIAA1849 PROTEIN

(Homo sapiens) 		PF00595
(PDZ) 		4 TYR A  39
GLN A  41
ILE A 103
ASP A  27
 None
 1.13A 2xytH-1um1A:
undetectable		 2xytH-1um1A:
18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v62 KIAA1719 PROTEIN

(Homo sapiens) 		PF00595
(PDZ) 		4 ARG A  48
ILE A  49
ASP A  65
SER A 104
 None
 1.12A 2xytH-1v62A:
undetectable		 2xytH-1v62A:
20.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vf8 SECRETORY PROTEIN

(Mus musculus) 		PF00704
(Glyco_hydro_18) 		4 GLN A 187
MET A   4
ILE A 240
SER A 180
 None
 1.12A 2xytH-1vf8A:
undetectable		 2xytH-1vf8A:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1vgq FORMYL-COENZYME A
TRANSFERASE

(Oxalobacter
formigenes) 		PF02515
(CoA_transf_3) 		4 THR A  45
TYR A  59
ARG A 376
ASP A  43
 None
 1.04A 2xytH-1vgqA:
undetectable		 2xytH-1vgqA:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wky ENDO-BETA-1,4-MANNAN
ASE

(Bacillus sp.
JAMB-602) 		PF00150
(Cellulase) 		4 THR A 407
GLN A 405
ARG A 403
ILE A 488
 None
 0.98A 2xytH-1wkyA:
undetectable		 2xytH-1wkyA:
19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xdx TCTEX1 LIGHT CHAIN
PROTEIN

(Chlamydomonas
reinhardtii) 		PF03645
(Tctex-1) 		4 THR A 108
MET A  71
ILE A  69
SER A  93
 None
 0.81A 2xytH-1xdxA:
undetectable		 2xytH-1xdxA:
18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xny PROPIONYL-COA
CARBOXYLASE COMPLEX
B SUBUNIT

(Streptomyces
coelicolor) 		PF01039
(Carboxyl_trans) 		4 TYR A 117
ARG A 162
MET A 125
ILE A 121
 None
 0.86A 2xytH-1xnyA:
undetectable		 2xytH-1xnyA:
18.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2afb 2-KETO-3-DEOXYGLUCON
ATE KINASE

(Thermotoga
maritima) 		PF00294
(PfkB) 		4 TYR A 268
ARG A 275
ILE A 270
SER A 265
 None
 1.01A 2xytH-2afbA:
undetectable		 2xytH-2afbA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2auk DNA-DIRECTED RNA
POLYMERASE BETA'
CHAIN

(Escherichia
coli) 		no annotation 4 THR A  85
GLN A 169
ILE A 167
ASP A  82
 None
 1.07A 2xytH-2aukA:
undetectable		 2xytH-2aukA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2d1g ACID PHOSPHATASE

(Francisella
tularensis) 		PF04185
(Phosphoesterase) 		4 TYR A 385
GLN A 436
ILE A 384
ASP A 387
 None
None
None
UNX  A 601 ( 2.6A)
 0.93A 2xytH-2d1gA:
undetectable		 2xytH-2d1gA:
19.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2efj 3,7-DIMETHYLXANTHINE
METHYLTRANSFERASE

(Coffea
canephora) 		PF03492
(Methyltransf_7) 		4 GLN A  40
ARG A  44
ILE A  39
ASP A  79
 None
 0.99A 2xytH-2efjA:
undetectable		 2xytH-2efjA:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f4l ACETAMIDASE,
PUTATIVE

(Thermotoga
maritima) 		PF03069
(FmdA_AmdA) 		4 TYR A 280
ARG A 243
ILE A 281
ASP A 214
 None
 1.11A 2xytH-2f4lA:
undetectable		 2xytH-2f4lA:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fk6 RIBONUCLEASE Z

(Bacillus
subtilis) 		PF12706
(Lactamase_B_2) 		4 GLN A 150
ARG A 148
ILE A 132
ASP A 153
 None
GOL  A 501 ( 4.0A)
None
None
 1.05A 2xytH-2fk6A:
undetectable		 2xytH-2fk6A:
21.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2it6 CD209 ANTIGEN

(Homo sapiens) 		PF00059
(Lectin_C) 		4 THR A 261
TYR A 268
ARG A 312
ILE A 376
 None
 0.95A 2xytH-2it6A:
undetectable		 2xytH-2it6A:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2m9u INTEGRASE P46

(Murine leukemia
virus) 		no annotation 4 THR A  85
MET A   9
ILE A  82
ASP A  60
 None
 0.95A 2xytH-2m9uA:
undetectable		 2xytH-2m9uA:
20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2o79 LYSOZYME

(Escherichia
virus T4) 		PF00959
(Phage_lysozyme) 		4 THR A  34
TYR A  25
ILE A  17
SER A  36
 None
 1.02A 2xytH-2o79A:
undetectable		 2xytH-2o79A:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qfq 3-PHOSPHOSHIKIMATE
1-CARBOXYVINYLTRANSF
ERASE

(Escherichia
coli) 		PF00275
(EPSP_synthase) 		4 GLN A 171
ARG A 100
ASP A 313
SER A 244
 S3P  A 701 (-4.0A)
None
S3P  A 701 ( 2.8A)
None
 1.12A 2xytH-2qfqA:
undetectable		 2xytH-2qfqA:
20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qgy ENOLASE FROM THE
ENVIRONMENTAL GENOME
SHOTGUN SEQUENCING
OF THE SARGASSO SEA

(-) 		PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C) 		4 ARG A  57
ILE A  61
ASP A 273
SER A 308
 None
 1.06A 2xytH-2qgyA:
undetectable		 2xytH-2qgyA:
18.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rpa KATANIN P60
ATPASE-CONTAINING
SUBUNIT A1

(Mus musculus) 		no annotation 4 TYR A  39
GLN A  35
ILE A   6
SER A  42
 None
 1.01A 2xytH-2rpaA:
undetectable		 2xytH-2rpaA:
15.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2uyy N-PAC PROTEIN

(Homo sapiens) 		PF03446
(NAD_binding_2)
PF14833
(NAD_binding_11) 		4 THR A 327
TYR A 357
ARG A 352
ILE A 351
 None
 1.01A 2xytH-2uyyA:
undetectable		 2xytH-2uyyA:
20.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ada SARCOSINE OXIDASE
BETA SUBUNIT

(Corynebacterium
sp. U-96) 		PF01266
(DAO) 		4 TYR B 292
GLN B 294
ARG B  63
ILE B 327
 None
None
FMN  B   4 ( 3.1A)
None
 1.10A 2xytH-3adaB:
undetectable		 2xytH-3adaB:
19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3e99 BENZOATE
1,2-DIOXYGENASE BETA
SUBUNIT

(Burkholderia
mallei) 		PF00866
(Ring_hydroxyl_B) 		4 THR A 114
TYR A 125
ILE A 163
SER A 116
 None
 1.08A 2xytH-3e99A:
undetectable		 2xytH-3e99A:
24.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3g9k CAPSULE BIOSYNTHESIS
PROTEIN CAPD

(Bacillus
anthracis) 		no annotation 4 THR S 363
MET L  99
ILE L 101
ASP S 359
 None
 1.07A 2xytH-3g9kS:
undetectable		 2xytH-3g9kS:
23.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hhr HUMAN GROWTH HORMONE

(Homo sapiens) 		PF00103
(Hormone_1) 		4 GLN A 122
MET A 125
ILE A 121
SER A  85
 None
 1.11A 2xytH-3hhrA:
undetectable		 2xytH-3hhrA:
19.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nvq SEMAPHORIN-7A

(Homo sapiens) 		PF01403
(Sema)
PF01437
(PSI)
PF13895
(Ig_2) 		4 TYR A 408
GLN A 304
ARG A 245
ASP A 432
 None
None
None
NDG  A   4 (-3.9A)
 1.08A 2xytH-3nvqA:
undetectable		 2xytH-3nvqA:
17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3olm E3 UBIQUITIN-PROTEIN
LIGASE RSP5

(Saccharomyces
cerevisiae) 		PF00397
(WW)
PF00632
(HECT) 		4 THR A 410
ARG A 436
ILE A 440
ASP A 407
 None
 1.05A 2xytH-3olmA:
undetectable		 2xytH-3olmA:
20.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pbl D(3) DOPAMINE
RECEPTOR, LYSOZYME
CHIMERA

(Escherichia
virus T4;
Homo sapiens) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		4 THR A1034
TYR A1025
ILE A1017
SER A1036
 None
 1.00A 2xytH-3pblA:
undetectable		 2xytH-3pblA:
18.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pdi NITROGENASE MOFE
COFACTOR
BIOSYNTHESIS PROTEIN
NIFE

(Azotobacter
vinelandii) 		PF00148
(Oxidored_nitro) 		4 TYR A 204
GLN A 419
ILE A 206
SER A 251
 None
 1.06A 2xytH-3pdiA:
undetectable		 2xytH-3pdiA:
16.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3psf TRANSCRIPTION
ELONGATION FACTOR
SPT6

(Saccharomyces
cerevisiae) 		PF14635
(HHH_7)
PF14639
(YqgF)
PF14641
(HTH_44)
PF14878
(DLD) 		4 TYR A 848
ILE A 813
ASP A 851
SER A1123
 None
 1.09A 2xytH-3psfA:
undetectable		 2xytH-3psfA:
13.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qak ADENOSINE RECEPTOR
A2A,LYSOZYME CHIMERA

(Escherichia
virus T4;
Homo sapiens) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		4 THR A1034
TYR A1025
ILE A1017
SER A1036
 None
 1.03A 2xytH-3qakA:
undetectable		 2xytH-3qakA:
17.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qd2 EUKARYOTIC
TRANSLATION
INITIATION FACTOR
2-ALPHA KINASE 3

(Mus musculus) 		PF00069
(Pkinase) 		4 TYR B 883
GLN B 885
ILE B 617
SER B 583
 None
 1.05A 2xytH-3qd2B:
undetectable		 2xytH-3qd2B:
21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rwr DNA REPAIR PROTEIN
XRCC4

(Homo sapiens) 		PF06632
(XRCC4) 		4 THR A  37
GLN A  21
ARG A   3
ILE A   5
 None
 0.80A 2xytH-3rwrA:
undetectable		 2xytH-3rwrA:
20.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sze SERINE PROTEASE ESPP

(Escherichia
coli) 		PF02395
(Peptidase_S6) 		4 TYR A 673
GLN A 691
ILE A 693
SER A 564
 None
 0.97A 2xytH-3szeA:
undetectable		 2xytH-3szeA:
12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3u7u RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-4

(Homo sapiens) 		PF00757
(Furin-like)
PF01030
(Recep_L_domain)
PF14843
(GF_recep_IV) 		4 THR A 151
ARG A 171
ILE A 141
SER A 148
 None
 1.06A 2xytH-3u7uA:
undetectable		 2xytH-3u7uA:
16.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ut3 PLASMINOGEN
ACTIVATOR INHIBITOR
1

(Homo sapiens) 		PF00079
(Serpin) 		4 THR A  49
GLN A  47
MET A  62
ILE A  58
 None
 1.14A 2xytH-3ut3A:
undetectable		 2xytH-3ut3A:
19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3v2y SPHINGOSINE
1-PHOSPHATE RECEPTOR
1, LYSOZYME CHIMERA
(E.C.3.2.1.17)

(Escherichia
virus T4;
Homo sapiens) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		4 THR A1034
TYR A1025
ILE A1017
SER A1036
 None
 1.13A 2xytH-3v2yA:
undetectable		 2xytH-3v2yA:
17.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3vw7 PROTEINASE-ACTIVATED
RECEPTOR 1, LYSOZYME

(Escherichia
virus T4;
Homo sapiens) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		4 THR A1034
TYR A1025
ILE A1017
SER A1036
 None
 1.02A 2xytH-3vw7A:
undetectable		 2xytH-3vw7A:
17.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w0d ELASTASE INHIBITOR
AFUEI

(Aspergillus
fumigatus) 		PF11720
(Inhibitor_I78) 		4 THR A  22
TYR A  21
GLN A  19
ILE A  62
 None
 1.05A 2xytH-3w0dA:
undetectable		 2xytH-3w0dA:
18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w9u PUTATIVE LIPASE

(Proteus
mirabilis) 		PF00561
(Abhydrolase_1) 		4 THR A 100
TYR A 194
ILE A 246
SER A  98
 None
 0.98A 2xytH-3w9uA:
undetectable		 2xytH-3w9uA:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4arp PESTICIN

(Yersinia pestis) 		PF16754
(Pesticin) 		4 GLN A 301
ARG A 339
MET A 336
SER A 197
 None
 1.09A 2xytH-4arpA:
undetectable		 2xytH-4arpA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bkg SMALL
UBIQUITIN-RELATED
MODIFIER 2

(Homo sapiens) 		PF11976
(Rad60-SLD) 		4 GLN A  88
ILE A  58
ASP A  26
SER A  28
 None
 1.12A 2xytH-4bkgA:
undetectable		 2xytH-4bkgA:
19.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4de8 CPS2A

(Streptococcus
pneumoniae) 		PF02916
(DNA_PPF)
PF03816
(LytR_cpsA_psr) 		4 TYR A 303
GLN A 475
MET A 478
ILE A 474
 None
 1.02A 2xytH-4de8A:
undetectable		 2xytH-4de8A:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4dkl MU-TYPE OPIOID
RECEPTOR, LYSOZYME
CHIMERA

(Escherichia
virus T4;
Mus musculus) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		4 THR A1034
TYR A1025
ILE A1017
SER A1036
 None
 1.08A 2xytH-4dklA:
undetectable		 2xytH-4dklA:
19.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4egj D-ALANINE--D-ALANINE
LIGASE

(Paraburkholderia
xenovorans) 		PF01820
(Dala_Dala_lig_N)
PF07478
(Dala_Dala_lig_C) 		4 TYR A  73
GLN A  80
ILE A  79
SER A  20
 None
 1.07A 2xytH-4egjA:
undetectable		 2xytH-4egjA:
19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4epi PESTICIN, LYSOZYME
CHIMERA

(Escherichia
virus T4;
Yersinia pestis) 		PF00959
(Phage_lysozyme) 		4 THR A 199
TYR A 190
ILE A 182
SER A 201
 None
 1.05A 2xytH-4epiA:
undetectable		 2xytH-4epiA:
19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gm6 PFKB FAMILY
CARBOHYDRATE KINASE

(Listeria grayi) 		PF00294
(PfkB) 		4 TYR A 257
ARG A 265
ILE A 259
SER A 254
 None
 1.13A 2xytH-4gm6A:
undetectable		 2xytH-4gm6A:
20.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i7l LYSOZYME

(Escherichia
virus T4) 		PF00959
(Phage_lysozyme) 		4 THR A  34
TYR A  25
ILE A  17
SER A  36
 None
 1.03A 2xytH-4i7lA:
undetectable		 2xytH-4i7lA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4igl YENB

(Yersinia
entomophaga) 		PF03534
(SpvB)
PF12255
(TcdB_toxin_midC)
PF12256
(TcdB_toxin_midN) 		4 GLN A 945
ARG A 930
ILE A 963
SER A1049
 None
 1.10A 2xytH-4iglA:
undetectable		 2xytH-4iglA:
8.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4imm OUTER MEMBRANE
ASSEMBLY LIPOPROTEIN
YFGL

(Moraxella
catarrhalis) 		PF13360
(PQQ_2) 		4 THR A 128
ILE A 134
ASP A 109
SER A 130
 None
 1.10A 2xytH-4immA:
undetectable		 2xytH-4immA:
21.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lde LYSOZYME, BETA-2
ADRENERGIC RECEPTOR

(Escherichia
virus T4;
Homo sapiens) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		4 THR A 899
TYR A 890
ILE A 882
SER A 901
 None
 1.08A 2xytH-4ldeA:
undetectable		 2xytH-4ldeA:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mtp RNA DEPENDENT RNA
POLYMERASE

(Japanese
encephalitis
virus) 		PF00972
(Flavi_NS5) 		4 THR A 574
TYR A 575
ARG A 568
ILE A 571
 THR  A 574 ( 0.8A)
TYR  A 575 ( 1.3A)
ARG  A 568 ( 0.6A)
ILE  A 571 ( 0.7A)
 1.06A 2xytH-4mtpA:
undetectable		 2xytH-4mtpA:
15.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4n9n STEROL UPTAKE
CONTROL PROTEIN 2,
LYSOZYME

(Escherichia
virus T4;
Saccharomyces
cerevisiae) 		PF00959
(Phage_lysozyme)
PF11951
(Fungal_trans_2) 		4 THR A1034
TYR A1025
ILE A1017
SER A1036
 None
 0.95A 2xytH-4n9nA:
undetectable		 2xytH-4n9nA:
18.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o87 N-TAGGED NUCLEASE

(Millerozyma
acaciae) 		no annotation 4 TYR A  46
GLN A  21
ILE A  17
ASP A  45
 None
 1.12A 2xytH-4o87A:
undetectable		 2xytH-4o87A:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qlo HOMOSERINE
O-ACETYLTRANSFERASE

(Staphylococcus
aureus) 		PF00561
(Abhydrolase_1) 		4 THR A  16
ILE A  22
ASP A 107
SER A  18
 None
 1.09A 2xytH-4qloA:
undetectable		 2xytH-4qloA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qsl PYRUVATE CARBOXYLASE

(Listeria
monocytogenes) 		no annotation 4 THR H 538
ILE H 556
ASP H 536
SER H 766
 None
 1.06A 2xytH-4qslH:
undetectable		 2xytH-4qslH:
11.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tn3 TRIM5/CYCLOPHILIN A
FUSION PROTEIN/T4
LYSOZYME CHIMERA

(Escherichia
virus T4;
Macaca mulatta) 		PF00643
(zf-B_box)
PF00959
(Phage_lysozyme) 		4 THR A 337
TYR A 328
ILE A 320
SER A 339
 None
 1.06A 2xytH-4tn3A:
undetectable		 2xytH-4tn3A:
18.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wn5 HYPOXIA-INDUCIBLE
FACTOR 3-ALPHA

(Homo sapiens) 		PF14598
(PAS_11) 		4 TYR A 275
ARG A 305
ILE A 278
ASP A 284
 None
 1.00A 2xytH-4wn5A:
undetectable		 2xytH-4wn5A:
19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wtv PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-BETA,ENDOLYSIN,PHO
SPHATIDYLINOSITOL
4-KINASE TYPE 2-BETA

(Escherichia
virus T4;
Homo sapiens) 		PF00454
(PI3_PI4_kinase)
PF00959
(Phage_lysozyme) 		4 THR A1033
TYR A1024
ILE A1016
SER A1035
 None
 1.14A 2xytH-4wtvA:
undetectable		 2xytH-4wtvA:
17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xee NEUROTENSIN RECEPTOR
TYPE 1, ENDOLYSIN
CHIMERA

(Escherichia
virus T4;
Rattus
norvegicus) 		PF00001
(7tm_1)
PF00959
(Phage_lysozyme) 		4 THR A1034
TYR A1025
ILE A1017
SER A1036
 None
 0.98A 2xytH-4xeeA:
undetectable		 2xytH-4xeeA:
16.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yh2 GLUTATHIONE S
TRANSFERASE E6

(Drosophila
melanogaster) 		PF13417
(GST_N_3)
PF14497
(GST_C_3) 		4 TYR A 139
ARG A 184
ILE A 185
ASP A 140
 None
 1.08A 2xytH-4yh2A:
undetectable		 2xytH-4yh2A:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4yx7 OXYGEN-REGULATED
INVASION PROTEIN
ORGB,ENDOLYSIN

(Escherichia
virus T4;
Salmonella
enterica) 		PF00959
(Phage_lysozyme) 		4 THR C  67
TYR C  58
ILE C  50
SER C  69
 None
 0.93A 2xytH-4yx7C:
undetectable		 2xytH-4yx7C:
21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zad FDC1

(Candida
dubliniensis) 		PF01977
(UbiD) 		4 MET A  99
ILE A  87
ASP A 328
SER A 321
 None
None
None
4LU  A 603 ( 3.7A)
 1.09A 2xytH-4zadA:
undetectable		 2xytH-4zadA:
20.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4zjs ACETYLCHOLINE
RECEPTOR SUBUNIT
ALPHA,SOLUBLE
ACETYLCHOLINE
RECEPTOR,ACETYLCHOLI
NE RECEPTOR SUBUNIT
ALPHA,SOLUBLE
ACETYLCHOLINE
RECEPTOR

(Aplysia
californica;
Homo sapiens) 		PF02931
(Neur_chan_LBD) 		7 THR A  36
GLN A  57
ARG A  59
MET A 116
ILE A 118
ASP A 164
SER A 167
 None
 0.44A 2xytH-4zjsA:
29.4		 2xytH-4zjsA:
78.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zwj CHIMERA PROTEIN OF
HUMAN RHODOPSIN,
MOUSE S-ARRESTIN,
AND T4 ENDOLYSIN

(Escherichia
virus T4;
Homo sapiens;
Mus musculus) 		PF00001
(7tm_1)
PF00339
(Arrestin_N)
PF00959
(Phage_lysozyme)
PF02752
(Arrestin_C)
PF10413
(Rhodopsin_N) 		4 THR A1034
TYR A1025
ILE A1017
SER A1036
 None
 1.03A 2xytH-4zwjA:
undetectable		 2xytH-4zwjA:
13.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bz6 LYSOZYME,CALCIUM
UNIPORTER PROTEIN,
MITOCHONDRIAL

(Escherichia
virus T4;
Homo sapiens) 		PF00959
(Phage_lysozyme) 		4 THR A  34
TYR A  25
ILE A  17
SER A  36
 None
 1.12A 2xytH-5bz6A:
undetectable		 2xytH-5bz6A:
18.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d6o HOMOSERINE
O-ACETYLTRANSFERASE

(Corynebacterium
glutamicum) 		PF00561
(Abhydrolase_1) 		4 TYR A 335
ARG A 317
ILE A 319
ASP A 340
 None
 1.00A 2xytH-5d6oA:
undetectable		 2xytH-5d6oA:
20.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5eut PHOSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA,ENDOLYSIN,PH
OSPHATIDYLINOSITOL
4-KINASE TYPE
2-ALPHA

(Escherichia
virus T4;
Homo sapiens) 		PF00454
(PI3_PI4_kinase)
PF00959
(Phage_lysozyme) 		4 THR A1036
TYR A1027
ILE A1019
SER A1038
 None
 1.07A 2xytH-5eutA:
undetectable		 2xytH-5eutA:
18.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fya PATATIN-LIKE
PROTEIN, PLPD

(Pseudomonas
aeruginosa) 		PF01734
(Patatin) 		4 TYR A  73
MET A  85
ILE A  81
SER A  71
 None
 1.11A 2xytH-5fyaA:
undetectable		 2xytH-5fyaA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gjw VOLTAGE-DEPENDENT
CALCIUM CHANNEL
SUBUNIT
ALPHA-2/DELTA-1

(Oryctolagus
cuniculus) 		PF00092
(VWA)
PF08399
(VWA_N)
PF08473
(VGCC_alpha2) 		4 MET F 404
ILE F 401
ASP F 261
SER F 265
 None
None
None
CA  F1201 (-2.7A)
 1.01A 2xytH-5gjwF:
undetectable		 2xytH-5gjwF:
11.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5h12 DEEP VENT DNA
POLYMERASE

(Pyrococcus) 		PF00136
(DNA_pol_B)
PF03104
(DNA_pol_B_exo1) 		4 TYR A 218
MET A 190
ILE A 157
ASP A 215
 None
 1.11A 2xytH-5h12A:
undetectable		 2xytH-5h12A:
13.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jbg LGP2

(Gallus gallus) 		PF00271
(Helicase_C)
PF04851
(ResIII)
PF11648
(RIG-I_C-RD) 		4 TYR A 287
GLN A 241
MET A 244
ILE A 240
 None
 1.13A 2xytH-5jbgA:
undetectable		 2xytH-5jbgA:
14.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nri D-ALANINE--D-ALANINE
LIGASE

(Burkholderia
pseudomallei) 		no annotation 4 TYR A  73
GLN A  80
ILE A  79
SER A  20
 None
 1.07A 2xytH-5nriA:
undetectable		 2xytH-5nriA:
17.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5sui RIBOSOME BIOGENESIS
PROTEIN NSA1

(Saccharomyces
cerevisiae) 		no annotation 4 THR A 341
GLN A 382
ARG A 390
SER A 309
 None
 1.10A 2xytH-5suiA:
undetectable		 2xytH-5suiA:
19.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t58 KLLA0C15939P
KLLA0D15741P

(Kluyveromyces
lactis) 		PF08202
(MIS13)
PF08641
(Mis14) 		4 TYR N 179
GLN D 439
ARG D 443
ILE N 182
 None
 1.06A 2xytH-5t58N:
undetectable		 2xytH-5t58N:
23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5v88 LYSOZYME,DCN1-LIKE
PROTEIN 1

(Escherichia
virus T4;
Homo sapiens) 		PF00959
(Phage_lysozyme)
PF03556
(Cullin_binding) 		4 THR A  34
TYR A  25
ILE A  17
SER A  36
 None
 1.00A 2xytH-5v88A:
undetectable		 2xytH-5v88A:
19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vba LYSOZYME, ESX-1
SECRETION-ASSOCIATED
PROTEIN ESPG1
CHIMERA

(Escherichia
virus T4;
Mycobacterium
kansasii) 		PF00959
(Phage_lysozyme)
PF14011
(ESX-1_EspG) 		4 THR A1034
TYR A1025
ILE A1017
SER A1036
 None
 1.06A 2xytH-5vbaA:
undetectable		 2xytH-5vbaA:
18.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wc1 MEIOTIC SPINDLE
FORMATION PROTEIN
MEI-1

(Caenorhabditis
elegans) 		PF00004
(AAA) 		4 TYR A 386
ARG A 367
ILE A 371
ASP A 387
 None
 1.05A 2xytH-5wc1A:
undetectable		 2xytH-5wc1A:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x5t ALPHA-KETOGLUTARIC
SEMIALDEHYDE
DEHYDROGENASE

(Azospirillum
brasilense) 		PF00171
(Aldedh) 		4 THR A 418
ILE A 261
ASP A 265
SER A 420
 None
 1.00A 2xytH-5x5tA:
undetectable		 2xytH-5x5tA:
19.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5xgl SOLUBLE
ACETYLCHOLINE
RECEPTOR

(Aplysia
californica) 		no annotation 5 THR A  34
GLN A  55
MET A 114
ILE A 116
SER A 164
 None
 1.00A 2xytH-5xglA:
31.7		 2xytH-5xglA:
100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5xgl SOLUBLE
ACETYLCHOLINE
RECEPTOR

(Aplysia
californica) 		no annotation 7 THR A  34
TYR A  53
GLN A  55
MET A 114
ILE A 116
ASP A 162
SER A 165
 None
 0.55A 2xytH-5xglA:
31.7		 2xytH-5xglA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5yhi PROTEIN YIIM

(Escherichia
coli) 		no annotation 4 GLN A 187
MET A 181
ILE A 177
SER A 167
 None
 1.11A 2xytH-5yhiA:
undetectable		 2xytH-5yhiA:
19.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5zbq NEUROPEPTIDE Y
RECEPTOR TYPE 1,T4
LYSOZYME

(Escherichia
virus T4;
Homo sapiens) 		no annotation 4 THR A1033
TYR A1024
ILE A1016
SER A1035
 None
 1.00A 2xytH-5zbqA:
undetectable		 2xytH-5zbqA:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b5d MEIOTIC SPINDLE
FORMATION PROTEIN
MEI-1

(Caenorhabditis
elegans) 		no annotation 4 TYR A 386
ARG A 367
ILE A 371
ASP A 387
 None
 1.07A 2xytH-6b5dA:
undetectable		 2xytH-6b5dA:
14.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6d1w POLYCYSTIN-2

(Homo sapiens) 		no annotation 4 THR A 260
GLN A 255
ARG A 251
SER A 286
 None
 0.95A 2xytH-6d1wA:
undetectable		 2xytH-6d1wA:
17.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6ffh METABOTROPIC
GLUTAMATE RECEPTOR
5,ENDOLYSIN

(Escherichia
virus T4;
Homo sapiens) 		no annotation 4 THR A1034
TYR A1025
ILE A1017
SER A1036
 None
 1.02A 2xytH-6ffhA:
undetectable		 2xytH-6ffhA:
17.05